Nitric oxide in shock (Q36835542)

16 August 2017

1 reference

title

Nitric oxide in shock (English)

1 reference

16 August 2017

Cauwels A

1

1 reference

PubMed ID

17538569

16 August 2017

language of work or name

English

0 references

publication date

30 May 2007

1 reference

16 August 2017

1 reference

16 August 2017

72

1 reference

16 August 2017

5

1 reference

16 August 2017

557-565

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ki.5002340

16 August 2017

0 references

cites work

Novel strategies for the treatment of sepsis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Novel therapies for sepsis: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Increasing evidence that the risks of rhAPC may outweigh its benefits.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

1 reference

7 January 2021

The epidemiology of sepsis in the United States from 1979 through 2000

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Severe sepsis and septic shock: review of the literature and emergency department management guidelines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Anaphylaxis in the United States: an investigation into its epidemiology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Role of endothelium-derived nitric oxide in the regulation of blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Is nitric oxide overproduction the target of choice for the management of septic shock?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Effects of a nitric oxide synthase inhibitor in humans with septic shock

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

NG-monomethyl-l-arginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

L-canavanine restores blood pressure in a rat model of endotoxic shock.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

cGMP-dependent protein kinases in drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Signaling for contraction and relaxation in smooth muscle of the gut.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

P-450 metabolites of arachidonic acid in the control of cardiovascular function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Evidence for, and importance of, cGMP-independent mechanisms with NO and NO donors on blood vessels and platelets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Acute renal failure and sepsis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Human monocytes/macrophages: NO or no NO?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

On the expression of nitric oxide synthase by human macrophages. Why no NO?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Expression of inducible nitric oxide synthase in circulating neutrophils of the systemic inflammatory response syndrome and septic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Nitric oxide synthase activity is increased in patients with sepsis syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Systemic NO production during (septic) shock depends on parenchymal and not on hematopoietic cells: in vivo iNOS expression pattern in (septic) shock.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Inducible nitric oxide synthase (iNOS) in endotoxemia: chimeric mice reveal different cellular sources in various tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

NO generation from nitrite and its role in vascular control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Blood Flow Regulation by S-Nitrosohemoglobin in the Physiological Oxygen Gradient

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

NO contest: nitrite versus S-nitroso-hemoglobin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Resistance to endotoxin shock in transgenic mice overexpressing endothelial nitric oxide synthase.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Cardiomyocyte-specific overexpression of nitric oxide synthase 3 prevents myocardial dysfunction in murine models of septic shock.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Lethality of endotoxin in mice genetically deficient in the respiratory burst oxidase, inducible nitric oxide synthase, or both.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Inducible nitric oxide synthase (iNOS) gene deficiency increases the mortality of sepsis in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Protection against TNF-induced lethal shock by soluble guanylate cyclase inhibition requires functional inducible nitric oxide synthase.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Dual role of endogenous nitric oxide in tumor necrosis factor shock: induced NO tempers oxidative stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Nitric oxide as a modulator of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Survival of TNF toxicity: dependence on caspases and NO.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Nitric oxide reaction with lipid peroxyl radicals spares alpha-tocopherol during lipid peroxidation. Greater oxidant protection from the pair nitric oxide/alpha-tocopherol than alpha-tocopherol/ascorbate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Selective NOS inhibition restores myocardial contractility in endotoxemic rats; however, myocardial NO content does not correlate with myocardial dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Biological effects of aminoguanidine: an update

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Therapeutic use of nitric oxide scavengers in shock and sepsis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Therapeutic effects of imidazolineoxyl N-oxide against endotoxin shock through its direct nitric oxide-scavenging activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Effects of carboxy-PTIO on systemic hemodynamics, liver energetics, and concentration of liver metabolites during endotoxic shock in rabbits: a 31P and 1H magnetic resonance spectroscopic study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Effects of nitric oxide scavenger, carboxy-PTIO on endotoxin-induced alterations in systemic hemodynamics in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Pyridoxalated hemoglobin polyoxyethylene: a nitric oxide scavenger with antioxidant activity for the treatment of nitric oxide-induced shock

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Activation of soluble guanylyl cyclase by a factor other than nitric oxide or carbon monoxide contributes to the vascular hyporeactivity to vasoconstrictor agents in the aorta of rats treated with endotoxin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Continuously infused methylene blue modulates the early cardiopulmonary response to endotoxin in awake sheep

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Methylene blue administration in septic shock: a clinical trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Does methylene blue administration to septic shock patients affect vascular permeability and blood volume?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Methylene blue: an old-timer or a compound ready for revival?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Inhibition of nitric oxide synthesis by methylene blue.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Methylene blue as an inhibitor of superoxide generation by xanthine oxidase. A potential new drug for the attenuation of ischemia/reperfusion injury.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

The selective guanylate cyclase inhibitor ODQ reduces multiple organ injury in rodent models of Gram-positive and Gram-negative shock

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Differential effects of a selective inhibitor of soluble guanylyl cyclase on global and regional hemodynamics during canine endotoxic shock

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Activation of vascular smooth muscle K+ channels by endothelium-derived relaxing factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

cGMP and S-nitrosylation: two routes for modulation of neuronal excitability by NO.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

MaxiK channel roles in blood vessel relaxations induced by endothelium-derived relaxing factors and their molecular mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

The pathogenesis of vasodilatory shock

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Role of KATP channels in sepsis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Hydrogen sulfide as a vasodilator

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

The ATP-sensitive K+ channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Glibenclamide-induced inhibition of the expression of inducible nitric oxide synthase in cultured macrophages and in the anaesthetized rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Glibenclamide, a blocker of ATP-sensitive potassium channels, reverses endotoxin-induced hypotension in pig.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Involvement of ATP-sensitive potassium channels in a model of a delayed vascular hyporeactivity induced by lipopolysaccharide in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Differential involvement of guanylate cyclase and potassium channels in nitric oxide-induced hyporesponsiveness to phenylephrine in endotoxemic rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Randomized, double-blind, placebo-controlled crossover pilot study of a potassium channel blocker in patients with septic shock

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Potassium channels and septic shock

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Endothelium-derived reactive oxygen species: their relationship to endothelium-dependent hyperpolarization and vascular tone.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Endothelium-derived hyperpolarizing factor: where are we now?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Effect of potassium channel and cytochrome P450 inhibition on transient hypotension and survival during lipopolysaccharide-induced endotoxic shock in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Calcium-activated potassium channels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

EDHF and endothelial potassiun channels: IKCa and SKCa

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

EDHF: new therapeutic targets?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Role of SK(Ca) and IK(Ca) in endothelium-dependent hyperpolarizations of the guinea-pig isolated carotid artery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice: key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Evidence That Humans Produce Less Nitric Oxide Than Experimental Animals in Septic Shock

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Role of nitric oxide in recombinant tumor necrosis factor-alpha-induced circulatory shock: a study in patients treated for cancer with isolated limb perfusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Membrane-permeable radical scavengers (tempol) for shock, ischemia-reperfusion injury, and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Immune cells: free radicals and antioxidants in sepsis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Anaphylaxis: a review of causes and mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

An inhibitor of nitric oxide production, NGnitro-L-arginine-methyl ester, improves survival in anaphylactic shock

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Nitric oxide synthase inhibition is detrimental to cardiac function and promotes bronchospasm in anaphylaxis in rabbits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Constitutive nitric oxide synthase inhibition combined with histamine and serotonin receptor blockade improves the initial ovalbumin-induced arterial hypotension but decreases the survival time in brown norway rats anaphylactic shock

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Anaphylactic shock depends on PI3K and eNOS-derived NO.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002340

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5002340

1 reference

16 August 2017

1 reference

PubMed ID

17538569